Vision Statement

• The Deane F. Johnson Center (JCNT) at UCLA will advance neurotherapeutics and drug development for new treatments of neurological diseases.

Mission Statement

• JCNT will provide an infrastructure that facilitates the efficient and timely accomplishment of clinical trials.
• JCNT will advance the science of clinical trials, including design, analysis and implementation of biomarkers.
• JCNT will provide high quality preceptorships and other forms of training to physicians-in-training, community practitioners, and pharmaceutical personnel.

Values

• Committed to capturing quality data in clinical trials for clinical trial sponsors.
• Committed to optimizing the experience of patients and their caregivers participating in clinical trials.
• Committed to integrating advances in basic science, imaging, genetics and other fields onto clinical trials methodology.
• Committed to providing optimal educational experiences for all educational program participants including, students, physicians-in-training, community practitioners and pharmaceutical personnel.
• Committed to enhancing information exchange among trialists to assist in advancement of clinical trial methodology, use of biomarkers, and understanding of mechanisms across diseases and among pharmaceutical agents.